- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.78 Å
- Oligo State
- monomer
- Ligands
- 1 x 01: (2P)-3-(3-chloro-2-methoxyanilino)-2-[3-({(2R)-1-[(2E)-4-(dimethylamino)but-2-enoyl]-2-methylpyrrolidin-2-yl}ethynyl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
01.1: 21 residues within 4Å:- Chain A: L.26, F.31, V.34, A.51, I.52, K.53, E.70, M.74, L.88, L.99, T.101, Q.102, L.103, M.104, C.108, D.111, R.152, N.153, L.155, T.165, D.166
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:L.26, A:F.31, A:F.31, A:V.34, A:A.51, A:K.53, A:T.101, A:L.155, A:T.165
- Hydrogen bonds: A:K.53, A:M.104, A:T.165, A:D.166, A:D.166, A:D.166
- Water bridges: A:N.153
- Salt bridges: A:D.111
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 9 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 4 residues within 4Å:- Chain A: S.268, P.270, E.274, E.278
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:E.278
- Water bridges: A:K.260, A:K.260, A:S.268, A:S.268, A:K.271, A:E.278
EDO.7: 5 residues within 4Å:- Chain A: K.22, K.36, G.37, L.38, E.316
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.22
EDO.8: 5 residues within 4Å:- Chain A: E.115, H.116, D.118, N.119, L.300
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:H.116, A:D.118, A:N.119
EDO.9: 7 residues within 4Å:- Chain A: W.216, K.224, Y.226, D.227, L.244, P.245
- Ligands: GOL.22
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Y.226, A:D.227
- Water bridges: A:S.223
EDO.10: 5 residues within 4Å:- Chain A: P.230, A.231, S.232
- Ligands: EDO.12, GOL.21
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.232, A:S.232
EDO.11: 4 residues within 4Å:- Chain A: T.220, F.221, G.222, S.223
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.223
- Water bridges: A:K.224
EDO.12: 8 residues within 4Å:- Chain A: K.190, I.229, P.230, A.231, L.328
- Ligands: EDO.10, EDO.13, GOL.19
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.190, A:K.190, A:A.231
EDO.13: 7 residues within 4Å:- Chain A: K.190, K.224, D.227, G.228, I.229
- Ligands: EDO.12, GOL.19
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.190, A:D.227, A:G.228, A:I.229
EDO.14: 3 residues within 4Å:- Chain A: K.16, E.17, L.93
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.17
- Water bridges: A:L.93
- 10 x GOL: GLYCEROL(Non-functional Binders)
GOL.15: 5 residues within 4Å:- Chain A: T.251, I.252, D.253, R.288, Y.289
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.251, A:D.253, A:D.253, A:R.288
GOL.16: 6 residues within 4Å:- Chain A: E.242, R.243, L.244, P.245, Y.255, R.259
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.243, A:R.243
- Water bridges: A:G.241, A:R.259
GOL.17: 4 residues within 4Å:- Chain A: M.256, K.260, M.263
- Ligands: GOL.18
2 PLIP interactions:2 interactions with chain A- Water bridges: A:R.259, A:R.259
GOL.18: 5 residues within 4Å:- Chain A: R.243, R.259, W.262
- Ligands: CL.2, GOL.17
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.259
- Water bridges: A:R.243
GOL.19: 4 residues within 4Å:- Chain A: G.228, P.230
- Ligands: EDO.12, EDO.13
No protein-ligand interaction detected (PLIP)GOL.20: 4 residues within 4Å:- Chain A: Q.123, N.127, A.283, R.284
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.127, A:N.127
GOL.21: 7 residues within 4Å:- Chain A: I.189, I.197, A.231, S.232, I.329, P.330
- Ligands: EDO.10
3 PLIP interactions:3 interactions with chain A- Water bridges: A:S.232, A:S.232, A:S.235
GOL.22: 6 residues within 4Å:- Chain A: Y.226, I.229, I.237, E.242, R.243
- Ligands: EDO.9
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.242, A:E.242
- Water bridges: A:E.242
GOL.23: 6 residues within 4Å:- Chain A: G.121, S.122, Q.123, P.286, Q.287, D.295
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:S.122, A:S.122, A:Q.123, A:Q.287, A:D.295
- Water bridges: A:Q.287, A:D.295, A:D.295
GOL.24: 4 residues within 4Å:- Chain A: P.248, C.250, T.251, V.291
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pagliarini, R.A. et al., STX-721, a covalent EGFR/HER2 exon 20 inhibitor, takes advantage of exon 20 mutant dynamic protein states and achieves unique mutant-selectivity across human cancer models. To Be Published
- Release Date
- 2025-05-14
- Peptides
- Epidermal growth factor receptor: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.78 Å
- Oligo State
- monomer
- Ligands
- 1 x 01: (2P)-3-(3-chloro-2-methoxyanilino)-2-[3-({(2R)-1-[(2E)-4-(dimethylamino)but-2-enoyl]-2-methylpyrrolidin-2-yl}ethynyl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 9 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 10 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pagliarini, R.A. et al., STX-721, a covalent EGFR/HER2 exon 20 inhibitor, takes advantage of exon 20 mutant dynamic protein states and achieves unique mutant-selectivity across human cancer models. To Be Published
- Release Date
- 2025-05-14
- Peptides
- Epidermal growth factor receptor: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A